SIBELIUM

This brand name is authorized in Austria, Spain, France, Ireland, Malta, Mexico, Netherlands, Romania, Turkey, South Africa

Active ingredients

The drug SIBELIUM contains one active pharmaceutical ingredient (API):

1 Flunarizine UNII C11102TO53 - FLUNARIZINE HYDROCHLORIDE

Flunarizine is a selective calcium entry blocker with calmodulin binding properties and histamine H1 blocking activity. It is effective in the prophylaxis of migraine, occlusive peripheral vascular disease, vertigo of central and peripheral origin, and as an adjuvant in the therapy of epilepsy. Read about Flunarizine

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
SIBELIUM Tablet	Health Products Regulatory Authority (IE)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
N07CA03	Flunarizine	N Nervous system → N07 Other nervous system drugs → N07C Antivertigo preparations → N07CA Antivertigo preparations
Discover more medicines within N07CA03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 55352
Country: FR	Base de données publique des médicaments	Identifier(s): 61247136
Country: IE	Health Products Regulatory Authority	Identifier(s): 45988
Country: MT	Medicines Authority	Identifier(s): AA1228/01601
Country: MX	Comisión Federal para la Protección contra Riesgos Sanitarios	Identifier(s): 444M96
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 29890
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W66819001
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699593015274, 8699593015281
Country: ZA	Health Products Regulatory Authority	Identifier(s): 43/5.7.1/0451, M/5.7.1/530